Conjugated linoleic acid (CLA): Is it time to supplement asthma therapy?

Pulmonary Pharmacology and Therapeutics

Volumn 24, Issue 5, 2011, Pages 540-548

  MacRedmond, Ruth ^a   Dorscheid, Delbert R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Adipokine; Asthma; Complementary and alternative medicine; Conjugated linoleic acid; PPARgamma

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPOCYTOKINE; ARACHIDONIC ACID; CONJUGATED LINOLEIC ACID; CYTOKINE; DOCOSAHEXAENOIC ACID; ICOSANOID; ICOSAPENTAENOIC ACID; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEUKOTRIENE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PLACEBO; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN; THROMBOXANE; TUMOR NECROSIS FACTOR ALPHA;

AIRWAY INFLAMMATION; ALLERGIC DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTIVIRAL ACTIVITY; ASTHMA; AUTOCRINE EFFECT; BODY MASS; CYTOKINE PRODUCTION; DIABETES MELLITUS; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE EXACERBATION; DRUG DESIGN; DRUG EFFICACY; DRUG MEGADOSE; DRUG METABOLISM; DRUG POTENCY; DRUG SAFETY; DRUG SYNTHESIS; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; HEREDITY; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOPATHOLOGY; INFLAMMATION; INSULIN RESISTANCE; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PARACRINE SIGNALING; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; RISK FACTOR; VIRUS INFECTION;

ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; CLINICAL TRIALS AS TOPIC; DIETARY SUPPLEMENTS; DRUG EVALUATION, PRECLINICAL; HUMANS; LINOLEIC ACIDS, CONJUGATED;

EID: 80052406895     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2011.03.005     Document Type: Review

References (121)

1. Masoli M., Fabian D., Holt S., Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004, 59(5):469-478.
2. Haney S., Hancox R.J. Recovery from bronchoconstriction and bronchodilator tolerance. Clin Rev Allergy Immunol 2006, 31(2-3):181-196.
3. Rossi G.A., Cerasoli F., Cazzola M. Safety of inhaled corticosteroids: room for improvement. Pulm Pharmacol Ther 2007, 20(1):23-35.
4. Elias J.A., Zhu Z., Chupp G., Homer R.J. Airway remodeling in asthma. J Clin Invest 1999, 104(8):1001-1006.
5. Tindle H.A., Davis R.B., Phillips R.S., Eisenberg D.M. Trends in use of complementary and alternative medicine by US adults: 1997-2002. Altern Ther Health Med 2005, 11(1):42-49.
6. Barnes P., Bloom B., Nahin R. CDC National Health Statistics Report #12. Complementary and alternative medicine use among adults and children 2007, United States, 2007.
7. Pariza M.W., Hargraves W.A. A beef-derived mutagenesis modulator inhibits initiation of mouse epidermal tumors by 7,12-dimethylbenz[a]anthracene. Carcinogenesis 1985, 6(4):591-593.
8. Chin S.F., Liu W., Storkson J.M., Ha Y.L., Pariza M.W. Dietary sources of conjugated Dienoic isomers of linoleic acids, a newly Recognized class of Anticarcinogens. J Food Comp Anal 1992, 5:185-197.
9. Parodi P.W. Cows' milk fat components as potential anticarcinogenic agents. J Nutr 1997, 127(6):1055-1060.
10. Park Y., Albright K.J., Liu W., Storkson J.M., Cook M.E., Pariza M.W. Effect of conjugated linoleic acid on body composition in mice. Lipids 1997, 32(8):853-858.
11. Kelley N.S., Hubbard N.E., Erickson K.L. Conjugated linoleic acid isomers and cancer. J Nutr 2007, 137(12):2599-2607.
12. Lee K.N., Kritchevsky D., Pariza M.W. Conjugated linoleic acid and atherosclerosis in rabbits. Atherosclerosis 1994, 108(1):19-25.
13. O'Shea M., Bassaganya-Riera J., Mohede I.C. Immunomodulatory properties of conjugated linoleic acid. Am J Clin Nutr 2004, 79(6 Suppl):1199S-1206S.
14. Kramer J.K., Cruz-Hernandez C., Deng Z., Zhou J., Jahreis G., Dugan M.E. Analysis of conjugated linoleic acid and trans 18:1 isomers in synthetic and animal products. Am J Clin Nutr 2004, 79(6 Suppl):1137S-1145S.
15. Fritsche J., Rickert R., Steinhart H. Advances in Conjugaed linoleic acid research 1999, AOCS Press, Champaign (IL).
16. McGuire M.A., McGuire M.K., Parodi P.W., Jensen R.G. Advances in conjugated linoleic acid research 1999, 296-306. AOCS Press, Champaign. M.P. Yurawecz, M.M. Mossoba, J.K.G. Kramer, M.W. Pariza, G.J. Nelson (Eds.).
17. Parodi P. Advances in conjugated linoleic acid research 2003, AOCS Press, Champaign, IL.
18. Saebo A. Advances in conjugated linoleic acid research 2003, AOCS Press, Champaign (IL).
19. Khan S.A., Vanden Heuvel J.P. Role of nuclear receptors in the regulation of gene expression by dietary fatty acids (review). J Nutr Biochem 2003, 14(10):554-567.
20. Eder W., Ege M.J., von Mutius E. The asthma epidemic. N Engl J Med 2006, 355(21):2226-2235.
21. Strachan D.P., Cook D.G. Health effects of passive smoking. 6. Parental smoking and childhood asthma: longitudinal and case-control studies. Thorax 1998, 53(3):204-212.
22. Hoffmann P., Mest H.J. What about the effects of dietary lipids on endogenous prostanoid synthesis? A state-of-the-art review. Biomed Biochim Acta 1987, 46(7):639-650.
23. Simopoulos A.P. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother 2006, 60(9):502-507.
24. Fogarty A., Britton J. The role of diet in the aetiology of asthma. Clin Exp Allergy 2000, 30(5):615-627.
25. Hunter J.E., Applewhite T.H. Isomeric fatty acids in the US diet: levels and health perspectives. Am J Clin Nutr 1986, 44(6):707-717.
26. Hunter J.E., Applewhite T.H. Reassessment of trans fatty acid availability in the US diet. Am J Clin Nutr 1991, 54(2):363-369.
27. Enig M.G., Atal S., Keeney M., Sampugna J. Isomeric trans fatty acids in the U.S. diet. J Am Coll Nutr 1990, 9(5):471-486.
28. Fritsche J., Steinhart H. Contents of trans-fatty acids (TFA) in German foods and evaluation of Daily intake. Fett/Lipids 1997, 99:314-318.
29. Fritsche J., Steinhart H. Amounts of conjugated linoleic acid (CLA) in German foods and evaluation of Daily intake. Z Lebensm Unters Forsch A 1998, 77-82.
30. Ritzenthaler K., McGuire M.K., Falen R., Shultz T.D., Mcguire M.A. Estimation of conjugated linoleic acid (CLA) intake. FASEB J 1998, 12:A527.
31. Mushtaq S., Heather Mangiapane E., Hunter K.A. Estimation of cis-9, trans-11 conjugated linoleic acid content in UK foods and assessment of dietary intake in a cohort of healthy adults. Br J Nutr 2010, 103(9):1366-1374.
32. Ritzenthaler K.L., McGuire M.K., Falen R., Shultz T.D., Dasgupta N., McGuire M.A. Estimation of conjugated linoleic acid intake by written dietary assessment methodologies underestimates actual intake evaluated by food duplicate methodology. J Nutr 2001, 131(5):1548-1554.
33. Greer F.R., Sicherer S.H., Burks A.W. Effects of early nutritional interventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas. Pediatrics 2008, 121(1):183-191.
34. Wijga A.H., Smit H.A., Kerkhof M., de Jongste J.C., Gerritsen J., Neijens H.J., et al. Association of consumption of products containing milk fat with reduced asthma risk in pre-school children: the PIAMA birth cohort study. Thorax 2003, 58(7):567-572.
35. Woods R.K., Walters E.H., Raven J.M., Wolfe R., Ireland P.D., Thien F.C., et al. Food and nutrient intakes and asthma risk in young adults. Am J Clin Nutr 2003, 78(3):414-421.
36. Ford E.S. The epidemiology of obesity and asthma. J Allergy Clin Immunol 2005, 115(5):897-909. quiz 10.
37. Beuther D.A., Sutherland E.R. Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med 2007, 175(7):661-666.
38. Hjellvik V., Tverdal A., Furu K. Body mass index as predictor for asthma: a cohort study of 118,723 males and females. Eur Respir J 2010, 35(6):1235-1242.
39. Stenius-Aarniala B., Poussa T., Kvarnstrom J., Gronlund E.L., Ylikahri M., Mustajoki P. Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study. BMJ 2000, 320(7238):827-832.
40. Weiss S.T. Obesity: insight into the origins of asthma. Nat Immunol 2005, 6(6):537-539.
41. Sood A., Verhulst S.J., Varma A., Eagleton L.E., Henkle J.Q., Hopkins-Price P. Association of excess weight and degree of airway responsiveness in asthmatics and non-asthmatics. J Asthma 2006, 43(6):447-452.
42. Shore S.A., Terry R.D., Flynt L., Xu A., Hug C. Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice. J Allergy Clin Immunol 2006, 118(2):389-395.
43. Sood A., Qualls C., Seagrave J., Stidley C., Archibeque T., Berwick M., et al. Effect of specific allergen inhalation on serum adiponectin in human asthma. Chest 2009, 135(2):287-294.
44. Bhattacharya A., Banu J., Rahman M., Causey J., Fernandes G. Biological effects of conjugated linoleic acids in health and disease. J Nutr Biochem 2006, 17(12):789-810.
45. Wang Y.W., Jones P.J. Conjugated linoleic acid and obesity control: efficacy and mechanisms. Int J Obes Relat Metab Disord 2004, 28(8):941-955.
46. Plourde M., Jew S., Cunnane S.C., Jones P.J. Conjugated linoleic acids: why the discrepancy between animal and human studies?. Nutr Rev 2008, 66(7):415-421.
47. Whigham L.D., Watras A.C., Schoeller D.A. Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans. Am J Clin Nutr 2007, 85(5):1203-1211.
48. Malpuech-Brugere C., Verboeket-van de Venne W.P., Mensink R.P., Arnal M.A., Morio B., Brandolini M., et al. Effects of two conjugated linoleic Acid isomers on body fat mass in overweight humans. Obes Res 2004, 12(4):591-598.
49. Riserus U., Arner P., Brismar K., Vessby B. Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care 2002, 25(9):1516-1521.
50. Takahashi Y., Kushiro M., Shinohara K., Ide T. Dietary conjugated linoleic acid reduces body fat mass and affects gene expression of proteins regulating energy metabolism in mice. Comp Biochem Physiol B Biochem Mol Biol 2002, 133(3):395-404.
51. Yamasaki M., Mansho K., Mishima H., Kasai M., Sugano M., Tachibana H., et al. Dietary effect of conjugated linoleic acid on lipid levels in white adipose tissue of Sprague-Dawley rats. Biosci Biotechnol Biochem 1999, 63(6):1104-1106.
52. Belury M.A., Mahon A., Banni S. The conjugated linoleic acid (CLA) isomer, t10c12-CLA, is inversely associated with changes in body weight and serum leptin in subjects with type 2 diabetes mellitus. J Nutr 2003, 133(1):257S-260S.
53. Medina E.A., Horn W.F., Keim N.L., Havel P.J., Benito P., Kelley D.S., et al. Conjugated linoleic acid supplementation in humans: effects on circulating leptin concentrations and appetite. Lipids 2000, 35(7):783-788.
54. Miller J.R., Siripurkpong P., Hawes J., Majdalawieh A., Ro H.S., McLeod R.S. The trans-10, cis-12 isomer of conjugated linoleic acid decreases adiponectin assembly by PPARgamma-dependent and PPARgamma-independent mechanisms. J Lipid Res 2008, 49(3):550-562.
55. Norris L.E., Collene A.L., Asp M.L., Hsu J.C., Liu L.F., Richardson J.R., et al. Comparison of dietary conjugated linoleic acid with safflower oil on body composition in obese postmenopausal women with type 2 diabetes mellitus. Am J Clin Nutr 2009, 90(3):468-476.
56. Hamid Q., Tulic M. Immunobiology of asthma. Annu Rev Physiol 2009, 71:489-507.
57. Daynes R.A., Jones D.C. Emerging roles of PPARs in inflammation and immunity. Nat Rev Immunol 2002, 2(10):748-759.
58. Klotz L., Schmidt S., Heun R., Klockgether T., Kolsch H. Association of the PPARgamma gene polymorphism Pro12Ala with delayed onset of multiple sclerosis. Neurosci Lett 2009, 449(1):81-83.
59. Regieli J.J., Jukema J.W., Doevendans P.A., Zwinderman A.H., van der Graaf Y., Kastelein J.J., et al. PPAR gamma variant influences angiographic outcome and 10-year cardiovascular risk in male symptomatic coronary artery disease patients. Diabetes Care 2009, 32(5):839-844.
60. Oh S.H., Park S.M., Lee Y.H., Cha J.Y., Lee J.Y., Shin E.K., et al. Association of peroxisome proliferator-activated receptor-gamma gene polymorphisms with the development of asthma. Respir Med 2009, 103(7):1020-1024.
61. Denning G.M., Stoll L.L. Peroxisome proliferator-activated receptors: potential therapeutic targets in lung disease?. Pediatr Pulmonol 2006, 41(1):23-34.
62. Pawliczak R., Han C., Huang X.L., Demetris A.J., Shelhamer J.H., Wu T. 85-kDa cytosolic phospholipase A2 mediates peroxisome proliferator-activated receptor gamma activation in human lung epithelial cells. J Biol Chem 2002, 277(36):33153-33163.
63. Benayoun L., Letuve S., Druilhe A., Boczkowski J., Dombret M.C., Mechighel P., et al. Regulation of peroxisome proliferator-activated receptor gamma expression in human asthmatic airways: relationship with proliferation, apoptosis, and airway remodeling. Am J Respir Crit Care Med 2001, 164(8 Pt 1):1487-1494.
64. Belvisi M.G., Mitchell J.A. Targeting PPAR receptors in the airway for the treatment of inflammatory lung disease. Br J Pharmacol 2009, 158(4):994-1003.
65. Kersten S., Desvergne B., Wahli W. Roles of PPARs in health and disease. Nature 2000, 405(6785):421-424.
66. Scher J.U., Pillinger M.H. 15d-PGJ2: the anti-inflammatory prostaglandin?. Clin Immunol 2005, 114(2):100-109.
67. Genovese T., Cuzzocrea S., Di Paola R., Mazzon E., Mastruzzo C., Catalano P., et al. Effect of rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 on bleomycin-induced lung injury. Eur Respir J 2005, 25(2):225-234.
68. Lee K.S., Park S.J., Kim S.R., Min K.H., Jin S.M., Lee H.K., et al. Modulation of airway remodeling and airway inflammation by peroxisome proliferator-activated receptor gamma in a murine model of toluene diisocyanate-induced asthma. J Immunol 2006, 177(8):5248-5257.
69. Lee S.Y., Kang E.J., Hur G.Y., Jung K.H., Jung H.C., Lee S.Y., et al. Peroxisome proliferator-activated receptor-gamma inhibits cigarette smoke solution-induced mucin production in human airway epithelial (NCI-H292) cells. Am J Physiol Lung Cell Mol Physiol 2006, 291(1):L84-L90.
70. Kim S.R., Lee K.S., Park H.S., Park S.J., Min K.H., Jin S.M., et al. Involvement of IL-10 in peroxisome proliferator-activated receptor gamma-mediated anti-inflammatory response in asthma. Mol Pharmacol 2005, 68(6):1568-1575.
71. Lee K.S., Park S.J., Hwang P.H., Yi H.K., Song C.H., Chai O.H., et al. PPAR-gamma modulates allergic inflammation through up-regulation of PTEN. FASEB J 2005, 19(8):1033-1035.
72. Woerly G., Honda K., Loyens M., Papin J.P., Auwerx J., Staels B., et al. Peroxisome proliferator-activated receptors alpha and gamma down-regulate allergic inflammation and eosinophil activation. J Exp Med 2003, 198(3):411-421.
73. Trifilieff A., Bench A., Hanley M., Bayley D., Campbell E., Whittaker P. PPAR-alpha and -gamma but not -delta agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF-kappaB-independent effect. Br J Pharmacol 2003, 139(1):163-171.
74. Richards D.B., Bareille P., Lindo E.L., Quinn D., Farrow S.N. Treatment with a peroxisomal proliferator activated receptor gamma agonist has a modest effect in the allergen challenge model in asthma: a randomised controlled trial. Respir Med 2010, 104(5):668-674.
75. Spears M., Donnelly I., Jolly L., Brannigan M., Ito K., McSharry C., et al. Bronchodilatory effect of the PPAR-gamma agonist rosiglitazone in smokers with asthma. Clin Pharmacol Ther 2009, 86(1):49-53.
76. Kennedy A., Chung S., LaPoint K., Fabiyi O., McIntosh M.K. Trans-10, cis-12 conjugated linoleic acid antagonizes ligand-dependent PPARgamma activity in primary cultures of human adipocytes. J Nutr 2008, 138(3):455-461.
77. Gardner O.S., Dewar B.J., Graves L.M. Activation of mitogen-activated protein kinases by peroxisome proliferator-activated receptor ligands: an example of nongenomic signaling. Mol Pharmacol 2005, 68(4):933-941.
78. Kelly D.P. The pleiotropic nature of the vascular PPAR gene regulatory pathway. Circ Res 2001, 89(11):935-937.
79. Moya-Camarena S.Y., Vanden Heuvel J.P., Blanchard S.G., Leesnitzer L.A., Belury M.A. Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARalpha. J Lipid Res 1999, 40(8):1426-1433.
80. Houseknecht K.L., Vanden Heuvel J.P., Moya-Camarena S.Y., Portocarrero C.P., Peck L.W., Nickel K.P., et al. Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem Biophys Res Commun 1998, 244(3):678-682.
81. Jaudszus A., Krokowski M., Mockel P., Darcan Y., Avagyan A., Matricardi P., et al. Cis-9, trans-11-conjugated linoleic acid inhibits allergic sensitization and airway inflammation via a PPARgamma-related mechanism in mice. J Nutr 2008, 138(7):1336-1342.
82. Harizi H., Corcuff J.B., Gualde N. Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology. Trends Mol Med 2008, 14(10):461-469.
83. Calder P.C. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006, 83(6 Suppl):1505S-1519S.
84. Healy D.A., Wallace F.A., Miles E.A., Calder P.C., Newsholm P. Effect of low-to-moderate amounts of dietary fish oil on neutrophil lipid composition and function. Lipids 2000, 35(7):763-768.
85. Reisman J., Schachter H.M., Dales R.E., Tran K., Kourad K., Barnes D., et al. Treating asthma with omega-3 fatty acids: where is the evidence? A systematic review. BMC Complement Altern Med 2006, 6:26.
86. Mickleborough T.D., Lindley M.R., Ionescu A.A., Fly A.D. Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma. Chest 2006, 129(1):39-49.
87. Urquhart P., Parkin S.M., Rogers J.S., Bosley J.A., Nicolaou A. The effect of conjugated linoleic acid on arachidonic acid metabolism and eicosanoid production in human saphenous vein endothelial cells. Biochim Biophys Acta 2002, 1580(2-3):150-160.
88. Ringseis R., Muller A., Herter C., Gahler S., Steinhart H., Eder K. CLA isomers inhibit TNFalpha-induced eicosanoid release from human vascular smooth muscle cells via a PPARgamma ligand-like action. Biochim Biophys Acta 2006, 1760(2):290-300.
89. Ochoa J.J., Farquharson A.J., Grant I., Moffat L.E., Heys S.D., Wahle K.W. Conjugated linoleic acids (CLAs) decrease prostate cancer cell proliferation: different molecular mechanisms for cis-9, trans-11 and trans-10, cis-12 isomers. Carcinogenesis 2004, 25(7):1185-1191.
90. Whigham L.D., Cook E.B., Stahl J.L., Saban R., Bjorling D.E., Pariza M.W., et al. CLA reduces antigen-induced histamine and PGE(2) release from sensitized guinea pig tracheae. Am J Physiol Regul Integr Comp Physiol 2001, 280(3):R908-R912.
91. Whigham L.D., Higbee A., Bjorling D.E., Park Y., Pariza M.W., Cook M.E. Decreased antigen-induced eicosanoid release in conjugated linoleic acid-fed guinea pigs. Am J Physiol Regul Integr Comp Physiol 2002, 282(4):R1104-R1112.
92. Yang M., Cook M.E. Dietary conjugated linoleic acid decreased cachexia, macrophage tumor necrosis factor-alpha production, and modifies splenocyte cytokines production. Exp Biol Med (Maywood) 2003, 228(1):51-58.
93. Yu Y., Correll P.H., Vanden Heuvel J.P. Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: evidence for a PPAR gamma-dependent mechanism. Biochim Biophys Acta 2002, 1581(3):89-99.
94. Turek J.J., Li Y., Schoenlein I.A., Allen K.G.D., Watkins B.A. Modulation of macrophage cytokine production by conjugated linoleic acids is influenced by the dietary n-6:n-3 fatty acid ratio. J Nutr Biochem 1998, 9(5):258-266. (9).
95. Jaudszus A., Foerster M., Kroegel C., Wolf I., Jahreis G. Cis-9, trans-11-CLA exerts anti-inflammatory effects in human bronchial epithelial cells and eosinophils: comparison to trans-10, cis-12-CLA and to linoleic acid. Biochim Biophys Acta 2005, 1737(2-3):111-118.
96. Kelley D.S., Warren J.M., Simon V.A., Bartolini G., Mackey B.E., Erickson K.L. Similar effects of c9, t11-CLA and t10, c12-CLA on immune cell functions in mice. Lipids 2002, 37(7):725-728.
97. Nugent A.P., Roche H.M., Noone E.J., Long A., Kelleher D.K., Gibney M.J. The effects of conjugated linoleic acid supplementation on immune function in healthy volunteers. Eur J Clin Nutr 2005, 59(6):742-750.
98. Turpeinen A.M., Ylonen N., von Willebrand E., Basu S., Aro A. Immunological and metabolic effects of cis-9, trans-11-conjugated linoleic acid in subjects with birch pollen allergy. Br J Nutr 2008, 100(1):112-119.
99. Sugano M., Tsujita A., Yamasaki M., Noguchi M., Yamada K. Conjugated linoleic acid modulates tissue levels of chemical mediators and immunoglobulins in rats. Lipids 1998, 33(5):521-527.
100. Yamasaki M., Chujo H., Hirao A., Koyanagi N., Okamoto T., Tojo N., et al. Immunoglobulin and cytokine production from spleen lymphocytes is modulated in C57BL/6J mice by dietary cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid. J Nutr 2003, 133(3):784-788.
101. Albers R., van der Wielen R.P., Brink E.J., Hendriks H.F., Dorovska-Taran V.N., Mohede I.C. Effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid (CLA) isomers on immune function in healthy men. Eur J Clin Nutr 2003, 57(4):595-603.
102. Song H.J., Grant I., Rotondo D., Mohede I., Sattar N., Heys S.D., et al. Effect of CLA supplementation on immune function in young healthy volunteers. Eur J Clin Nutr 2005, 59(4):508-517.
103. Johnston S.L., Pattemore P.K., Sanderson G., Smith S., Lampe F., Josephs L., et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. Bmj 1995, 310(6989):1225-1229.
104. Nicholson K.G., Kent J., Ireland D.C. Respiratory viruses and exacerbations of asthma in adults. Bmj 1993, 307(6910):982-986.
105. Bassaganya-Riera J., Pogranichniy R.M., Jobgen S.C., Halbur P.G., Yoon K.J., O'Shea M., et al. Conjugated linoleic acid ameliorates viral infectivity in a pig model of virally induced immunosuppression. J Nutr 2003, 133(10):3204-3214.
106. Hayden F., O'Shea M. Effect of conjugated linoleic acid on experimental rhinovirus Illness. Anti-viral therapy advances conference 2004, Tuscon, AZ.
107. Singhera G.K., MacRedmond R., Dorscheid D.R. PPAR-Dependent inhibition of viral airway inflammation by CLA. Am J Respir Crit Care Med 2009, 1(79):A2815. Vancouver, Canada, 2009.
108. Singhera G.K., MacRedmond R., Wadsworth S.J., Dorscheid D.R. CLA inhibits RSV entry and cytopathic effect in isolated airway epithelial cells. Am J Respir Crit Care Med 2010, 179:A6187. 2010.
109. MacRedmond R., Singhera G., Attridge S., Bahzad M., Fava C., Lai Y., et al. Conjugated linoleic acid improves airway hyper-reactivity in overweight mild asthmatics. Clin Exp Allergy 2010, 40(7):1071-1078.
110. USFDA. Dietary supplements - Consumer Information http://www.fda.gov/Food/DietarySupplements/ConsumerInformation/ucm110417.htm%23safe.
111. Pariza M.W. Perspective on the safety and effectiveness of conjugated linoleic acid. Am J Clin Nutr 2004, 79(6 Suppl):1132S-1136S.
112. Riserus U., Vessby B., Arner P., Zethelius B. Supplementation with trans10cis12-conjugated linoleic acid induces hyperproinsulinaemia in obese men: close association with impaired insulin sensitivity. Diabetologia 2004, 47(6):1016-1019.
113. Moloney F., Yeow T.P., Mullen A., Nolan J.J., Roche H.M. Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. Am J Clin Nutr 2004, 80(4):887-895.
114. Riserus U., Smedman A., Basu S., Vessby B. Metabolic effects of conjugated linoleic acid in humans: the Swedish experience. Am J Clin Nutr 2004, 79(6 Suppl):1146S-1148S.
115. Noone E.J., Roche H.M., Nugent A.P., Gibney M.J. The effect of dietary supplementation using isomeric blends of conjugated linoleic acid on lipid metabolism in healthy human subjects. Br J Nutr 2002, 88(3):243-251.
116. Gaullier J.M., Berven G., Blankson H., Gudmundsen O. Clinical trial results support a preference for using CLA preparations enriched with two isomers rather than four isomers in human studies. Lipids 2002, 37(11):1019-1025.
117. Syvertsen C., Halse J., Hoivik H.O., Gaullier J.M., Nurminiemi M., Kristiansen K., et al. The effect of 6 months supplementation with conjugated linoleic acid on insulin resistance in overweight and obese. Int J Obes (Lond) 2007, 31(7):1148-1154.
118. Gaullier J.M., Halse J., Hoye K., Kristiansen K., Fagertun H., Vik H., et al. Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. J Nutr 2005, 135(4):778-784.
119. Smedman A., Basu S., Jovinge S., Fredrikson G.N., Vessby B. Conjugated linoleic acid increased C-reactive protein in human subjects. Br J Nutr 2005, 94(5):791-795.
120. Steck S.E., Chalecki A.M., Miller P., Conway J., Austin G.L., Hardin J.W., et al. Conjugated linoleic acid supplementation for twelve weeks increases lean body mass in obese humans. J Nutr 2007, 137(5):1188-1193.
121. Ramakers J.D., Plat J., Sebedio J.L., Mensink R.P. Effects of the individual isomers cis-9, trans-11 vs. trans-10, cis-12 of conjugated linoleic acid (CLA) on inflammation parameters in moderately overweight subjects with LDL-phenotype B. Lipids 2005, 40(9):909-918.